Historical record - last NADAC effective date: 8/23/2023
Product Information
DEXTROAMPHETAMINE 5 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3846 per EA under NDC 43386087001. Its NADAC has been published 354 times since Nov 16, 2016.
FDA first approved this application on Mar 16, 2016. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386087001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA204330FDA Approved
3/16/2016
TE Code
AA
On Market Since
4/25/2016
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE 5 MG TAB has been published 354 times since Nov 16, 2016, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3846 per EA |
|---|---|
| All-time high | $1.3752 (Mar 15, 2017) |
| All-time low | $0.1051 (Mar 17, 2021) |
| Median price | $0.3878 |
| Average price | $0.5447 |
| Largest weekly change | +121.3% (Apr 21, 2021) |
| Weeks tracked | 354 |
| Tracking since | Nov 16, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+51.1%
All
-70.4%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextroamphetamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE 5 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.3846 per EA (NDC 43386087001), effective Aug 23, 2023.
How has the price of DEXTROAMPHETAMINE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE 5 MG TAB has declined 70.4%. It has been tracked across 354 weekly CMS publications since Nov 16, 2016.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE 5 MG TAB?
Since Nov 16, 2016, the NADAC for DEXTROAMPHETAMINE 5 MG TAB has ranged from a low of $0.1051 (Mar 17, 2021) to a high of $1.3752 (Mar 15, 2017), with a median of $0.3878 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE 5 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMPHETAMINE 5 MG TAB, is $0.3836 per EA — about 0% below DEXTROAMPHETAMINE 5 MG TAB.
Who manufactures DEXTROAMPHETAMINE 5 MG TAB?
DEXTROAMPHETAMINE 5 MG TAB (NDC 43386087001) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.